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Edited by Ivan SadowskiAbstract Silencing of the transcriptional repressor REST is re-
quired for terminal diﬀerentiation of neuronal and b-cells. In this
study, we hypothesized that REST expression is controlled by
hairy and enhancer of split 1 (HES-1), a transcriptional repres-
sor that plays an important role in brain and pancreas develop-
ment. We identiﬁed several N elements (CTNGTG) within the
promoter of REST and conﬁrmed that HES-1 associates with
the endogenous promoter of REST. Moreover, using a cells model
that overexpress HES-1 and a combination of experimental ap-
proaches, we demonstrated that HES-1 reduces endogenous
REST expression. Taken together, these results indicate that
HES-1 is an upstream negative regulator of REST expression.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pancreatic b-cells and neuronal cells share several common
features, including restricted expression of genes that are tar-
gets of the RE1 silencer transcription factor (REST) [1,2].
REST is absent in mature b-cells and present only at very
low levels (inactive levels) in neuronal cells [1,3–5]. This allows
the expression of a speciﬁc set of genes that are silenced by
REST in non-neuronal and non-b-cells [6–8]. REST target
genes have been identiﬁed and most of them are mandatory
for neuronal and b-cell function [3,9–12]. Thus, elucidation
of the transcriptional mechanisms that prevent REST expres-
sion is central for understanding the program leading to termi-
nal diﬀerentiation of neuronal and b-cells.
Hairy and enhancer of split homolog-1 (HES-1) is a basic
helix–loop–helix (bHLH) transcriptional repressor that plays
an essential role during early diﬀerentiation of neuroendocrine
tissues [13–16]. HES-1 either antagonizes positive bHLH tran-
scription factors through the E box (CANNTG) or directly
binds to the N box (CACNAG or CTNGTG) and recruits a
complex with co-repressors [17–19]. HES-1 is mostly present
in pre-diﬀerentiated cells and its disappearance during devel-
opment allows expression of genes important for neuronal*Corresponding author. Fax: +41 21 692 51 05.
E-mail address: amar.abderrahmani@unil.ch (A. Abderrahmani).
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doi:10.1016/j.febslet.2005.09.093and islet cell diﬀerentiation such as Neurogenin 3 (Ngn3), a
marker of mature endocrine cells [20].
In this study, we explored the possibility that HES-1 might
negatively regulate the expression of REST. Several N ele-
ments within the promoter of REST that bind HES-1 were
identiﬁed. To conﬁrm the regulation of REST by HES-1, we
established HeLa cell models in which HES-1 was reintro-
duced. Chromatin immunoprecipitation assays demonstrated
that HES-1 binds to the endogenous REST promoter and
leads to a decrease in REST cellular content and in its tran-
scriptional activity. These data establish HES-1 as a negative
regulator of REST expression and suggest its possible involve-
ment in REST silencing during terminal diﬀerentiation of neu-
roendocrine cells.2. Materials and methods
2.1. Plasmids construction
The plasmid encoding HES-1 was constructed by inserting the PCR-
ampliﬁed HES-1 cDNA. Primers were designed to amplify the full
length open reading frame of human HES-1 from human insulinoma
cells [21] and were: sense 5 0-AAGCTTGGATCCATGCCAGC-
TGATATAATGGAGA-30 and antisense 5 0-GGGCCCTCTAGAT-
CAGTTCCGCCACGGCCTCCA-3 0. The PCR fragment (0.84 Kb)
was inserted in BamHI and XbaI cloning sites of pcDNA3
(Invitrogen). To generate the Green Fluorescent Protein tagged
HES-1 construct (HES-1-GFP), the HES-1 cDNA was subcloned in
frame in BamHI and XbaI cloning sites of GFP-pcDNA3. Sequ-
ence analysis of inserts was performed by Microsynth (Balgach,
Switzerland).
2.2. Cell lines, transient transfection and luciferase assays
Human carcinoma HeLa cells were cultured and transiently trans-
fected using the Eﬀectene transfection Kit (Qiagen) as described [8].
Total protein extraction and luciferase reporter assays were performed
as described [8].
2.3. RNA preparation, RT-PCR and Northern blot analyses
Total RNA extraction was conducted as described [3]. For RT-PCR,
5 lg of total RNA were reverse transcribed with the superscript II re-
verse transcriptase, using random hexamers [pd(N)6] as primers. For
REST detection, 22 cycles of PCR were required and consisted of
95 C for 30 s, 52 C for 30 s, and 72 C for 3 s, followed by 5 min
extension at 72 C. Primer sets used for human REST were as follows:
sense 5 0-GTGACCGCTGCGGCTACAATACTAA-3 0 and antisense
5 0-GGACAAGTAGGATGCTTAGATTTGA-3 0. For detection of
ubiquitous cytochrome oxydase 4 mRNA (COX4), 24 cycles of PCR
were performed using the following sense and antisense primers: 5 0-
ATGTTGGCTTCCAGAGCGCTGA-3 0 and 5 0-CTTCTTCCACTC-
ATTCTTGTCATAG-3 0. Northern blot analyses were performed as
described [3].blished by Elsevier B.V. All rights reserved.
Table 1
Identiﬁcation of N boxes (CACNAG or CTNGTG) within the human
and mouse promoter of REST
Sequence Location
Mouse* Human1
(N1) CACCAG or CTGGTG 366/361; 4104/4099
1258/1253 8521/8516
2377/2372; 5168/5163
5410/5405
(N2) CACTAG or CTAGTG 298/293;
1792/1787
3275/3270;
4352/4347
5191/5186;
5542/553
(N3) CACAAG or CTTGTG 350/345; 4754/4749
1508/1503 6838/6833
3492/3487 10274/10269
(N4) CACGAG or CTCGTG 75/70; 6141/6136
687/682 11241/11236
*The positions of N elements are referred to the transcription start site
in the mouse promoter (23), or 1 upstream the ATG (A +1) in the
human promoter of REST.
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electromobility shift assays
Nuclear protein extracts and electromobility shift assays (EMSA)
were performed as previously reported [3]. Primers used as labeled
probes were as follows: NRSE: sense, 5 0-GGCTTCAGCACCGCG-
GAGAGCGCCATCTCC-30 and antisense: 5 0-CCGGAGATGGCG-
CTCTCCGCGGTGCTGAAG-3 0; N1 element from the human
promoter of REST: sense, 5 0-TTTCACCAGGAGGG-30 and antisense
5 0-CTCCTGGTGAAA-30; N2 (mouse), sense 5 0-CACACAC-
TAGATGG-3 0 and antisense 5 0-CCATCTAGTGTGTG-3 0; N3
(human), sense 5 0-AGTTCTCTTGTGTAAAT-3 0 and antisense
5 0-ATTTACACAAGAGAACT-30; N4 (human), sense 5 0-CTCA-
CCACACCAGCTAT-3 0 and antisense 5 0-ATAGCTGGTGTGGT-
GAG-3 0. N sequences are in bold and underlined. For supershift
assays, 5–10 lg of nuclear proteins were preincubated on ice with or
without HES-1 (Santa-Cruz biotechnology) or REST antibodies
(Santa-Cruz biotechnology) for 30 min before addition of the labeled
probe. Western blots were carried out as described [8].
2.5. Chromatin immunoprecipitation
Chromatin immunoprecipitation (CHIP) studies were performed
essentially as described [22]. Precleared cell lysates were incubated over-
night at 4 C with 5 lg Cyclin-A antibody (Upstate Biotechnology) or
4 lg HES-1 antibody (Santa Cruz Biotechnology). 5 ll of DNA wereFig. 1. HES-1 binds N elements found within the promoter of REST.
(A) EMSA experiments were performed using nuclear extracts from
HeLa cells transiently expressing HES-1. Extracts were then incubated
with 32P-labeled N1 sequence of the human promoter of REST. The
HES-1 binding pattern (HES-1) was disrupted using HES-1 antibodies
but not with the unrelated Sp1 antibody in nuclear extracts from cells
overexpressing HES-1, *non-speciﬁc. (B) The HES-1 binding pattern
was competed by adding a 100- (+) and 1000- (++) fold molar excess of
unlabeled N1, N2, N3 and N4 sequences but not with the unspeciﬁc
sequences (OCT1, Sp1 and CRE). (C) HES-1 eﬃciently reduces the
transcriptional activity through N1 element. The N1 sequence was
cloned as dimers upstream a SV40 promoter (Nluc). Constructs were
then transiently co-transfected into HeLa cells with the plasmid
encoding HES-1 (HES1) (+, 0.05 lg; ++, 0.1 lg and +++, 0.3 lg).
HES-1 decreased the luciferase activity of the Nluc in a dose-dependent
manner. Experiments were performed at least three times in triplicate.
All values are expressed as percent of the SV40LUC activity. Results are
expressed as means ± S.E.M. (**P < 0.01; ***P < 0.001).
cused for PCR to detect the presence of speciﬁc DNA segments with
the following primers; REST: sense 5 0-AGAGCAGGCAGGGAGA-
TTTT-3 0 and antisense 5 0-GACCATCCTTACCCATGTCG-3 0; cyclin
D2: sense 5 0-CCTGGAGTGAAATACACCAAAGGGC-3 0 and
antisense 5 0-CCTCACTCTGCCAGGCTTTCTCC-30; p27kip1: sense
5 0-CGGCCGTTTGGCTAGTTTGTTTGT-30 and antisense 5 0-AAC-
CCAGCCGCTCTCCAAACCTTG-3.
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3.1. Identiﬁcation of N elements within the promoter of REST
A search for N elements (CTNGTG or CACNAG) within
the mouse promoter [23] and human 5 0 regulatory region ofREST led to the identiﬁcation of several potential HES-1 bind-
ing sequences located within the 10Kb adjacent to the transcrip-
tional (mouse) and translational start sites (human) (Table 1).
The capacity of HES-1 to bind to the N elements identiﬁed
in the REST promoter was veriﬁed by EMSA. Nuclear ex-
tracts from HeLa cells transiently overexpressing HES-1 were
incubated with the N1 consensus sequence (located in the hu-
man promoter of REST at position 4104 to 4099 bp) as la-
beled probe. A diﬀerent binding pattern was detected in
nuclear extracts from control and HES-1 transfected HeLa
cells (Fig. 1A). To formerly conﬁrm the presence of HES-1
in the binding complex, nuclear extracts were preincubated
with HES-1 antibodies. Only the band speciﬁcally observed
in HES-1 overexpressing cells was supershifted by addition
of HES-1 antibodies, indicating that endogenous HES-1 bind-
ing activity is undetectable in control HeLa cells and that
HES-1 is able to bind to the N1 element (Fig. 1A). Three other
oligonucleotides containing N elements present in the pro-
moter of REST (N2, N3 and N4) were tested for their capacity
to bind HES-1. All these oligonucleotides competed with the
N1 sequence and formed a complex with HES-1 (Fig. 1B).
To assess the silencing activity of N elements, two N1 elements
were cloned upstream to a luciferase reporter gene under the
control of an SV40 promoter (Nluc). This construct was tran-
siently co-transfected in HeLa cells with increasing amounts of
HES-1 encoding plasmid. HES-1 expression did not aﬀect the
amount of luciferase produced from the SV40luc control plas-
mid but decreased in a dose-dependent manner the luciferase
activity obtained from Nluc (Fig. 1C). These results indicate
that HES-1 is able to repress the promoter activity through
the N elements found in the human promoter of REST.
3.2. HES-1 negatively regulates the expression of REST
We established a cell model in which HES-1 is constitutively
expressed. HeLa cells were stably transfected with a plasmid
encoding HES-1 under the control of the CMV promoter.
Neomycin-resistant clones were assessed for the expression ofFig. 2. Establishment of a cell model overexpressing HES-1. (A)
Northern blot analysis of exogenous HES-1 and b-actin mRNA in
HeLa cells. Total RNA (15 lg) was isolated from neomycin-resistant
clones transfected with CMV-HES-1 (HES1) (H1, H2 and H3) and
randomly selected controls (C1, C2 and C3). RNA was then hybridized
with the human HES-1 cDNA probe as previously described [3]. The
b-actin probe is used to evaluate the quantity of the total RNA loaded.
A transcript is detected only in H1, H2 and H3 but not in control cells.
(B) A HES-1 binding activity is detected in HES-1-expressing clones.
EMSA was performed with 32P-labeled N1 using nuclear extracts from
control C1/C2/C3 and H1/H2/H3 clones. A pattern of HES-1 binding
activity was detected with HES-1 expressing clones compared to free
probe migration. (C) This HES-1-binding activity was disrupted in
nuclear extracts from the H3 clone by using HES-1 antibodies but not
with unrelated Sp1 antibodies. Competition experiments showed that
the HES-1 binding pattern is competed by adding a 100- (+) and 1000-
(++) fold molar excess of unlabeled N1 but not with an unspeciﬁc Sp1
sequence. The arrow corresponds to a speciﬁc band for HES-1. (D)
Occupancy of the promoter of REST by HES-1. Formaldehyde cross-
linked chromatin samples from control HeLa cells (C1) and the clone
overexpressing HES-1 (H3) cells were used for immunoprecipitation
reaction with antibodies against HES-1 (Anti-HES-1) and cyclin A
(Anti-CA) as a negative control. As a control of PCR, DNA aliquots
from pre-immunoprecipitated samples (input) were used. DNA was
analyzed by PCR with speciﬁc primers corresponding to REST.
Primers speciﬁc to cyclin D2 and p27kip1 were used as negative and
positive controls, respectively, for the binding of HES-1.
b
Fig. 3. The expression of REST is downregulated in cells overexpressing HES-1. (A) mRNA levels of REST were decreased in HeLa cells expressing
HES-1. Total RNAs from control and from H1, H2 and H3 cells were analyzed for REST and cytochrome oxidase 4(COX4) genes expression by RT-
PCR using speciﬁc primer pair as described in Section 2. The densitometric measurement revealed a decrease by 50% of REST mRNA levels in clones
expressing HES-1 compared to control cells. (B) The REST-binding activity is decreased in HES-1 expressing cells. EMSA experiments were
performed using the REST binding sequence (NRSE) from the MAPK8IP1 promoter as the labeled probe [3]. A similar REST binding pattern was
observed in control (C) and in HES-1 expressing-clones (h). The addition of REST antibodies (+REST) in nuclear extracts from H1 and C1 clones
disrupted the REST-binding activity (indicated by the arrow REST) whereas unrelated antibodies did not inhibit nor supershift the REST pattern
(data not shown). The REST-binding activity was reduced in clones expressing HES-1 compared to control cells. As previously described [3], the
arrows () correspond to the unspeciﬁc binding activity that was not competed in competition experiments using the cold probe NRSE IB1 (data not
shown). (C) The REST-transcriptional repressive activity is reduced by HES-1. Clones and control cells were transiently transfected with NRSEluc to
measure the activity of REST. As expected, the luciferase activity of NRSEluc was drastically reduced in control cells [3]. However, this activity was
signiﬁcantly increased in all clones expressing HES-1, indicating a loss of REST activity. (D) The mutation in NRSE did not modify the
transcriptional activity of NRSEluc in clones expressing HES-1, indicating that the eﬀect observed in (C) was speciﬁc to REST activity. Experiments
were performed at least ﬁve times in triplicate. Results were expressed as means ± S.E.M.
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expressed clearly detectable levels of HES-1 while no signal
was obtained in three randomly selected C1, C2 and C3 con-
trol clones transfected with an empty vector (Fig. 2A). HES-
1-binding activity was evaluated by incubating nuclear extracts
prepared from the diﬀerent clones with the labeled N1 probe.
As expected, a HES-1 binding activity was observed in all
clones overexpressing HES-1 but not in control clones
(Fig. 2B and C). Chromatin immunoprecipitation experiments
were performed in control C1 and H3 clones using a primer set
designed to encompass the N1 element within the human
REST promoter. As a positive control for the binding of
HES-1, a primer set that encompass the p27kip1 promoter
was used [24]. The results in Fig. 2D demonstrate that HES-
1 associates with the human REST promoter.
Next we measured REST mRNA levels in clones expressing
HES-1. RT-PCR analyses showed that in all clones transfectedwith HES-1 REST mRNA levels are decreased by about 50%
(Fig. 3A). This ﬁnding was veriﬁed by EMSA analyses. For
this purpose, nuclear extracts obtained from the diﬀerent
clones were incubated with the neuron restrictive silencer
element (NRSE) of theMAPK8IP1 promoter as labeled probe.
This element has been previously described to bind speciﬁcally
REST and to silence the transcriptional activity of an SV40
promoter (SV40luc) [3]. The REST binding activity was lower
in all clones expressing HES-1 compared to controls (Fig. 3B).
Reduction of REST transcriptional activity was functionally
conﬁrmed by measuring the expression of a luciferase reporter
gene under the control of NRSE. We used luciferase encoding
constructs containing two wild type (NRSEluc) or mutated
NRSE motifs (mNRSEluc) cloned upstream of SV40 promoter
[3]. In control cells, the luciferase activity driven by NRSEluc
was drastically decreased by 80% (Fig. 3C). In contrast, in cells
expressing HES-1, the luciferase activity generated from NRS-
Fig. 4. Transient expression of HES-1 increases the activity of a
REST-dependent promoter. NRSEluc construct was transiently co-
transfected with HES1 (+, 0.05 lg; ++, 0.1 lg and +++, 0.3 lg) in
HeLa cells. As expected, in the absence of HES1, the activity of
NRSEluc was reduced compared to that of SV40luc. In the presence of
HES-1, the NRSEluc activity increased in a dose-dependent manner.
Experiments were performed at least ﬁve times in triplicate. Results
were expressed as means ± S.E.M. (**P < 0.01).
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Fig. 5. The HES-1 mediated repression is TSA-sensitive. The Nluc
construct was transiently co-transfected in HeLa cells with HES-1
(0.1 lg). 100 nM of TSA (+) or DMSO () as control were added to
medium 24 h after transfection. The HES-1 mediated repression of the
Nluc was relieved in TSA-treated cells. Experiments were performed at
least ﬁve times in triplicate. Results were expressed as means ± S.E.M.
(**P < 0.01).
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This eﬀect is speciﬁcally linked to a decrease in REST activity
because when the NRSE motifs of NRSEluc were mutated the
amount of luciferase produced was not signiﬁcantly diﬀerent
from controls (Fig. 3D). These results were reproduced by
transiently co-transfecting HeLa cells with HES-1 and NRS-
Eluc. Overexpression of HES-1 allowed an increase in NRS-
Eluc activity as a result of a reduced expression of REST
(Fig. 4).
Recruitment of co-repressors and histone deacetylases
(HDAC) is one mode of transcriptional repression when
HES-1 is targeted to DNA [18,19]. We next veriﬁed whether
HES-1-mediated REST repression through the N element is
sensitive to trichostatin (TSA), a speciﬁc inhibitor of histone
deacetylase activity [25]. As expected, overexpression of HES-1
decreased the activity of the Nluc. This eﬀect was abrogated
in the presence of TSA (Fig. 5) indicating that HES-1-mediated
repression of REST through the N element requires the recruit-
ment of histone deacetylases.4. Discussion
The transcriptional repressor REST is absent in neuronal
and b-cells. In this report, we investigated the possible contri-
bution of HES-1 in abrogating REST expression. We identiﬁed
several N elements in human and mouse REST promoters.
EMSA experiments and luciferase assays conﬁrmed the func-
tionality of these elements and CHIP experiments demon-
strated direct binding of HES-1 to the REST promoter. The
regulatory domains of the mouse REST gene have been charac-
terized and contain three promoters, six enhancer regions and
two silencer regions [23]. One repressor domain (A) has been
localized between (598 to 2549 bp) and another (B) in the
untranslated region at +1156 to +1529 bp [23]. Deletion of si-
lencer region A leads to a very strong induction of the promoter
activity in neuroblastoma cells [23]. Based on our observations,
the silencer region A contains six putative functional N motifs
(Table 1). Therefore, the relieved activity of the REST pro-moter deleted of region A may be due at least in part to the loss
of HES-1-controlled N elements. Functional studies validated
the negative role of HES-1 on REST expression. Indeed, rein-
troduction of HES-1 in HeLa cells consistently reduced endog-
enous levels of REST. HES-1 is known to interact with the
complex including groucho (Gro)/transducin like enhancer of
split (TLE) co-repressors [19]. The association of TLE with
HDACs [19] implicates that HES-1-mediated active repression
depends on histone deacetylases activities (HDACs). In agree-
ment with this mechanism, we showed that inhibition of
HDACs by TSA abolishes HES-1-mediated silencing. Thus,
HES-1-induced hypoacetylation around the N elements could
change the local nucleosomal structure and, thereby, directly
aﬀect transcription factor activities on the REST promoter.
The eﬀect of HES-1 on REST expression uncovered in
this study has relevant implications for understanding the
mechanism controlling cell fate during neuronal and b-cell
diﬀerentiation. Indeed, HES-1 has been shown to operate
as a major repressor during endocrine cell diﬀerentiation
[14,16]. We propose that HES-1 contributes to silence the
expression of REST permitting the establishment of appro-
priate cellular functions [26,27]. This silencing eﬀect may
be important for acquisition of a speciﬁc gene expression
pattern and may be restricted to precise developmental
stages. In fact, HES-1 expression peaks during development
of pancreatic islets and is then reduced in mature b-cells
[16]. Thus, it is likely that in mature b-cells additional tran-
scription factors will contribute to regulate the expression of
REST as this is the case for other HES-1 target genes such
as Ngn3 [20].
In conclusion, our data have identiﬁed HES-1 as a negative
regulator of REST expression providing the basis for future
investigations on the precise contribution of HES-1 to the
silencing of REST for b-cell and neuronal diﬀerentiation
throughout the diﬀerent developmental stages.
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